禁煙・ニコチン依存症治療製品市場レポート：2030年までの動向、予測、競合分析

禁煙・ニコチン依存症治療製品の動向と予測

世界の禁煙・ニコチン依存症治療製品市場は、2024年から2030年にかけてCAGR 16.0％で成長すると予測されます。この市場の主な促進要因は、喫煙に伴う健康リスクと禁煙のメリットに対する意識の高まり、タバコの箱のグラフィック警告や公共の場での喫煙禁止などの規制強化です。世界の禁煙・ニコチン依存症治療製品市場の将来は、病院薬局、オンライン業者、ドラッグストア、小売薬局市場に機会があり、有望視されています。

• Lucintelの予測では、ニコチン代替療法製品の需要拡大により、ガムが引き続き最大セグメントとなります。
• この市場の中では、急速なデジタル化、購入の容易さ、製品の迅速な配達により、オンライン業者が最も高い成長を示すと予想されます。
• 北米は、政府のイニシアチブの増加、整備された医療インフラの存在、同地域における電子タバコの高い採用率により、予測期間中も最大地域であり続けると思われます。

よくある質問

Q1.市場の成長予測は：

A1.世界の禁煙・ニコチン依存症治療製品市場は、2024年から2030年にかけてCAGR 16.0％で成長すると予想されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、喫煙に伴う健康リスクと禁煙のメリットに対する意識の高まり、タバコの箱のグラフィック警告や公共の場での禁煙といった規制の強化です。

Q3.市場の主要セグメントは：

A3.禁煙・ニコチン依存症治療製品市場の将来は、病院薬局、オンライン業者、ドラッグストア、小売薬局市場に機会があり、有望です。

Q4.市場の主要企業は：

A4.禁煙・ニコチン依存症治療製品の主要企業は以下の通り：

• Pfizer
• Imperial Brands
• Njoy Company
• GlaxoSmithKline
• British American Tobacco
• Perrigo Company
• Johnson and Johnson
• Rusan Pharma
• Dr. Reddy's Laboratories
• 22nd Century

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、ニコチン代替療法製品への需要の高まりにより、ガムが最大のセグメントであり続けると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.北米は、政府のイニシアチブの増加、整備された医療インフラの存在、同地域における電子タバコの高い普及率により、予測期間中最大の地域であり続けます。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の禁煙・ニコチン依存症治療製品市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の禁煙・ニコチン依存症治療製品市場の動向（2018～2023年）と予測（2024～2030年）
• 形態別世界の禁煙・ニコチン依存症治療製品市場
  • ガム
  • 吸入器
  • 錠剤
  • その他
• 禁煙・ニコチン依存症治療製品の世界市場（製品別）
  • ニコチン代替療法製品
  • 薬物療法
  • 電子タバコ
• 世界の禁煙・ニコチン依存症治療製品市場（流通チャネル別）
  • 病院薬局
  • オンライン業者
  • ドラッグストアと薬局

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別禁煙・ニコチン依存症治療製品の世界市場
• 北米の禁煙・ニコチン依存症治療製品市場
• 欧州の禁煙・ニコチン依存症治療製品市場
• アジア太平洋の禁煙・ニコチン依存症治療製品市場
• その他地域禁煙・ニコチン依存症治療製品市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 形態別世界の禁煙・ニコチン依存症治療製品市場の成長機会
  • 禁煙・ニコチン依存症治療製品市場における製品別の成長機会
  • 世界の禁煙・ニコチン依存症治療製品市場における流通チャネル別の成長機会
  • 地域別の世界の禁煙・ニコチン依存症治療製品市場の成長機会
• 世界の禁煙・ニコチン依存症治療製品市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の禁煙・ニコチン依存症治療製品市場の生産能力拡大
  • 世界の禁煙・ニコチン依存症治療製品市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Pfizer
• Imperial Brands
• Njoy Company
• GlaxoSmithKline
• British American Tobacco
• Perrigo Company
• Johnson and Johnson
• Rusan Pharma
• Dr. Reddy's Laboratories
• 22nd Century

Smoking Cessation and Nicotine De-Addiction Products Trends and Forecast

The future of the global smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets. The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030. The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

• Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.
• Within this market, online provider is expected to witness highest growth due to rapid digitalization, ease of purchase, and quicker delivery of products.
• North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Emerging Trends in the Smoking Cessation and Nicotine De-Addiction Products Market

A few factors act as the backbone of ongoing development in the Smoking Cessation and Nicotine De-Addiction Products market. The key trends are driven by both technological advancement and changes in consumer behavior. These trends constitute the very basis for innovations and further their market scope.

• Digital Therapeutics: Digital tools and mobile apps are increasingly being employed in smoking cessation, offering personalized support and real-time monitoring. Such technologies amplify user engagement and deliver customized strategies to improve quit rates.
• Nicotine Replacement Therapies: Advancement in NRTs, along with their newer modes of delivery and formulation, upsurges the degree of efficiency for them. Better products, like nicotine patches and gums, assist users in being less dependent more effectively.
• Integration of Telehealth Services: Telehealth services for quitting smoking are being increasingly integrated into smoking cessation programs to ensure remote consultations, support, and monitoring for easier access and increased commitment to quitting.
• Behavioral Support Programs: More emphasis is put on combining nicotine de-addiction products with behavioral therapy. Indeed, integrated programs addressing the physical and psychological aspects of addiction have tended to be more effective.
• Harm Reduction Strategies: This trend influences the market by focusing on harm reduction, using e-cigarettes as a less harmful alternative to smoking. Harm reduction strategies seek to reduce the health risks of traditional smoking.

These trends reshape the Smoking Cessation and Nicotine De-Addiction Products market, and are therefore configured to improve both treatment outcomes and access to cessation resources.

Recent Developments in the Smoking Cessation and Nicotine De-Addiction Products Market

New developments within the Smoking Cessation and Nicotine De-Addiction Products market have been a highlight of key development areas. These further illustrate key innovations and the increased drive to overcome nicotine addiction.

• Introduction of New NRT Products: New formulations and delivery methods for nicotine replacement therapies, such as enhanced patches and gums, are raising efficacy and user satisfaction to support more successful quit attempts.
• Improving Access to Digital Support Tools: Advanced digital platforms and mobile applications introduce users to personalized quit plans and support, making it easier for them to track their progress and receive tailored advice.
• Inclusion of Telehealth Services: Telehealth integrated into smoking cessation programs enables remote consultations and monitoring, increasing the ease with which users can access professional support.
• Behavioral Therapy Programs: Combined approaches, wherein nicotine de-addiction products are combined with behavioral therapy, are gaining popularity. These approaches address the physical and psychological components of addiction for better outcomes.
• Growth of Harm Reduction Approaches: An increase in harm reduction strategies, including the use of e-cigarettes and other alternatives, reflects the shift toward less harmful options among smokers looking to quit.

These factors are increasing the efficacy and accessibility of smoking-cessation products, further improving the outcomes of public health.

Strategic Growth Opportunities for Smoking Cessation and Nicotine De-Addiction Products Market

The Smoking Cessation and Nicotine De-Addiction Products market has several strategic growth opportunities across a number of different applications. Identification of these opportunities shall facilitate further growth and innovation in the market.

• Integration of Telehealth: Such use of telehealth in smoking cessation programs can thus be extended to a wide segment of the population and provide support even from a distance, further facilitating the convenience and success of the quitting process.
• Digital Therapeutics: Further development of digital therapeutic solutions, such as mobile applications and online platforms, is bound to offer personalized support and monitoring, increasing the degree of engagement and success rates among those who quit smoking.
• Improved NRT Development: The development of newer, more efficient nicotine replacement products and better delivery mechanisms would fulfill the changing needs of quitting smokers.
• Integration of Behavioral Therapy: Comprehensive behavioral therapy in conjunction with nicotine de-addiction products will provide a more holistic approach toward quitting and thereby improve overall treatment outcomes.
• Harm Reduction Products: Investing in harm reduction strategies, including e-cigarettes and alternative nicotine delivery systems, opens new paths for smokers looking for less harmful ways to quit.

In the broader perspective, these growth opportunities tend to have their impact on the Smoking Cessation and Nicotine De-Addiction Products market, increasing the options for treatment and improving their accessibility and effectiveness.

Smoking Cessation and Nicotine De-Addiction Products Market Driver and Challenges

The Smoking Cessation and Nicotine De-Addiction Products market is surrounded by various technological, economic, and regulatory factors. Understanding these drivers and challenges will be important in navigating this landscape.

The factors responsible for driving the smoking cessation and nicotine de-addiction products market include:

1. Technological Advances: Innovations within the area of nicotine replacement treatments and digital technologies further enhance their efficacy and user experience, hence driving better market growth and quit rates.

2. Increased Public Awareness: Growing awareness of the health risks associated with smoking and the benefits of cessation products is boosting demand and encouraging more individuals to seek help. Accessibility of Services: More and more smoking cessation programs and products are becoming increasingly available through telehealth and other digital avenues, improving accessibility and support for users.

3. Increased Focus on Harm Reduction: The emphasis on harm reduction strategies-like e-cigarettes-opens new avenues in the market, providing alternative options for people who want to quit smoking.

Challenges in the smoking cessation and nicotine de-addiction products market are:

1. Advanced Product Cost: Some of the advanced products for quitting smoking come at a high cost, and such costs ultimately reduce access and adoption, particularly in low-income and resource-poor situations.

2. Regulatory Barriers: Complex regulatory requirements and lengthy approval processes make market entry difficult for new products and challenging for market entrants to find their way through the system.

3. Saturation of Market: The market is reaching saturation in terms of the various options that people trying to give up smoking are being presented with, and this will test new entrants in finding ways of differentiating their offerings to capture and build a market share.

These drivers and challenges are helping shape the Smoking Cessation and Nicotine De-Addiction Products market, consequently driving growth, innovation, and overall market dynamics.

List of Smoking Cessation and Nicotine De-Addiction Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies smoking cessation and nicotine de-addiction products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smoking cessation and nicotine de-addiction products companies profiled in this report include-

• Pfizer
• Imperial Brands
• Njoy Company
• GlaxoSmithKline
• British American Tobacco
• Perrigo Company
• Johnson and Johnson
• Rusan Pharma
• Dr. Reddy's Laboratories
• 22nd Century

Smoking Cessation and Nicotine De-Addiction Products by Segment

The study includes a forecast for the global smoking cessation and nicotine de-addiction products by form, product, distribution channel, and region.

Smoking Cessation and Nicotine De-Addiction Products Market by Form [Analysis by Value from 2018 to 2030]:

• Gum
• Inhaler
• Tablet
• Others

Smoking Cessation and Nicotine De-Addiction Products Market by Product [Analysis by Value from 2018 to 2030]:

• Nicotine Replacement Therapy Products
• Drug Therapy
• E-cigarettes

Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel [Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Online Provider
• Drug stores and Retail Pharmacies

Smoking Cessation and Nicotine De-Addiction Products Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Smoking Cessation and Nicotine De-Addiction Products Market

The market of Smoking Cessation and Nicotine De-Addiction Products is an ever-evolving field, seeing new technologies, change in regulations, and increase in public health initiatives. Here's an overview of recent developments in the United States, China, Germany, India, and Japan.

• United States: There is growing adoption of advanced quitting products in the U.S. market, including digital therapeutics and prescription medications. Increasingly, personalized treatment plans and telehealth services that promote smoking cessation have been the focus.
• China: The market is also growing in China, with new government initiatives on reducing smoking rates. Innovative nicotine replacement therapies and better access to cessation support programs are on the rise, showing the country's commitment to public health.
• Germany: In Germany, the trend now is to combine smoking cessation products with behavioral therapies. Development involves new approaches in nicotine replacement therapies and mobile applications for smoking cessation support to bring better overall efficacy.
• India: The Indian market is gaining momentum due to growing awareness of the health hazards caused by smoking. New nicotine replacement products and the expansion of smoking cessation programs, including community-based interventions, are mooted for dealing with the high rate of smoking.
• Japan: Japan is forging ahead in putting a strong emphasis on reducing smoking through harm reduction strategies. New nicotine delivery systems and quitting initiatives with support from health campaigns and cessation programs are some of the trends being witnessed.

Features of the Global Smoking Cessation and Nicotine De-Addiction Products Market

Market Size Estimates: Smoking cessation and nicotine de-addiction products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smoking cessation and nicotine de-addiction products market size by form, product, distribution channel, and region in terms of value ($B).

Regional Analysis: Smoking cessation and nicotine de-addiction products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different forms, products, distribution channels, and regions for the smoking cessation and nicotine de-addiction products market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smoking cessation and nicotine de-addiction products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the growth forecast for smoking cessation and nicotine de-addiction products market?

Answer: The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the smoking cessation and nicotine de-addiction products market?

Answer: The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

Q3. What are the major segments for smoking cessation and nicotine de-addiction products market?

Answer: The future of the smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets.

Q4. Who are the key smoking cessation and nicotine de-addiction products market companies?

Answer: Some of the key smoking cessation and nicotine de-addiction products companies are as follows:

• Pfizer
• Imperial Brands
• Njoy Company
• GlaxoSmithKline
• British American Tobacco
• Perrigo Company
• Johnson and Johnson
• Rusan Pharma
• Dr. Reddy's Laboratories
• 22nd Century

Q5. Which smoking cessation and nicotine de-addiction products market segment will be the largest in future?

Answer: Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Q6. In smoking cessation and nicotine de-addiction products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the smoking cessation and nicotine de-addiction products market by form (gum, inhaler, tablet, and others), product (nicotine replacement therapy products, drug therapy, and e-cigarettes), distribution channel (hospital pharmacies, online provider, and drug stores and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Smoking Cessation and Nicotine De-Addiction Products Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Smoking Cessation and Nicotine De-Addiction Products Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Smoking Cessation and Nicotine De-Addiction Products Market by Form
  • 3.3.1: Gum
  • 3.3.2: Inhaler
  • 3.3.3: Tablet
  • 3.3.4: Others
• 3.4: Global Smoking Cessation and Nicotine De-Addiction Products Market by Product
  • 3.4.1: Nicotine Replacement Therapy Products
  • 3.4.2: Drug Therapy
  • 3.4.3: E-cigarettes
• 3.5: Global Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel
  • 3.5.1: Hospital Pharmacies
  • 3.5.2: Online Provider
  • 3.5.3: Drug stores and Retail Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Smoking Cessation and Nicotine De-Addiction Products Market by Region
• 4.2: North American Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.2.1: North American Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.2.2: North American Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
• 4.3: European Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.3.1: European Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.3.2: European Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
• 4.4: APAC Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.4.1: APAC Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.4.2: APAC Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
• 4.5: ROW Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.5.1: ROW Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.5.2: ROW Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Form
  • 6.1.2: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Product
  • 6.1.3: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Region
• 6.2: Emerging Trends in the Global Smoking Cessation and Nicotine De-Addiction Products Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Smoking Cessation and Nicotine De-Addiction Products Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smoking Cessation and Nicotine De-Addiction Products Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: Imperial Brands
• 7.3: Njoy Company
• 7.4: GlaxoSmithKline
• 7.5: British American Tobacco
• 7.6: Perrigo Company
• 7.7: Johnson and Johnson
• 7.8: Rusan Pharma
• 7.9: Dr. Reddy's Laboratories
• 7.10: 22nd Century